#1
Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
🧠 While peer support and self-help applications like Marijuana Anonymous can provide accessible, low-cost resources for patients seeking to reduce or abstain from cannabis use, clinicians should recognize that digital recovery platforms have not been systematically evaluated in rigorous trials and their efficacy remains unclear. The popularity of such apps reflects genuine patient demand for support, yet we lack standardized outcome data comparing app-based interventions to evidence-based treatments like cognitive-behavioral therapy or motivational interviewing, particularly for cannabis use disorder. Important confounders include variable user engagement, self-selection bias (highly motivated individuals are more likely to download and use such apps), and the heterogeneity of cannabis-related problems—ranging from mild psychological dependence to severe disorder with comorbid psychiatric or substance use conditions. Rather than viewing apps as standalone treatments, clinicians can integrate them as adjunctive supports within a comprehensive care plan, while maintaining direct assessment of cannabis use patterns,
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
